B cell High Density Microparticles - BioTransplant

Drug Profile

B cell High Density Microparticles - BioTransplant

Alternative Names: B cell HDM - BioTransplant; B cell-SC cell separation system

Latest Information Update: 24 Feb 2004

Price : $50

At a glance

  • Originator BioTransplant (CEASED)
  • Class Immunoconjugates; Monoclonal antibodies
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Lymphoma

Most Recent Events

  • 24 Feb 2004 BioTransplant has ceased operations
  • 28 Nov 2003 BioTransplant expects to file with the Bankruptcy Court in the coming weeks
  • 28 Nov 2003 Discontinued - Phase-II for Lymphoma in USA (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top